Compare FUL & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FUL | ICUI |
|---|---|---|
| Founded | 1887 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | 2007 | 1995 |
| Metric | FUL | ICUI |
|---|---|---|
| Price | $59.30 | $122.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $68.40 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 361.8K | 239.3K |
| Earning Date | 03-25-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | 19.57 | ★ 100.62 |
| EPS | 0.38 | ★ 1.20 |
| Revenue | ★ $2,897,000,000.00 | $2,231,262,000.00 |
| Revenue This Year | $4.96 | N/A |
| Revenue Next Year | $4.00 | $4.46 |
| P/E Ratio | $156.42 | ★ $101.70 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $48.71 | $107.02 |
| 52 Week High | $68.63 | $160.29 |
| Indicator | FUL | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 48.30 |
| Support Level | $59.23 | $121.52 |
| Resistance Level | $60.26 | $125.00 |
| Average True Range (ATR) | 1.74 | 4.65 |
| MACD | -0.25 | 0.64 |
| Stochastic Oscillator | 25.64 | 50.10 |
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.